menu search

Gri bio (nasdaq: gri) to participate in the virtual investor ask the ceo conference

– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday, October 24th at 11:00 AM ET LA JOLLA, CA, Oct. 11, 2023 (GL...

October 11, 2023, 1:05 pm

Gri bio to present at the h.c. wainwright 25th annual global investment conference

LA JOLLA, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing a...

September 6, 2023, 9:05 am

Axcella health stock rockets on long covid patent win

Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a pa...

August 29, 2023, 9:28 am

Unleashing the light: optical modulators market sales set to surpass us$ 57.8 billion by 2033 with photonics technology advancements | future market insights, inc.

Photonics technology, with its focus on generating, manipulating, and detecting light, is playing a pivotal role in enhancing optical ...

July 19, 2023, 12:30 am

Atossa therapeutics strikes sponsored research deal with weill cornell medicine for triple negative breast cancer

Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, announced a sponsored research agreement wit...

July 6, 2023, 12:26 pm

Bionomics announces key leadership updates to drive u.s.-focused transformation and next stage of strategic growth

Alan Fisher appointed Chair of the Board of Directors Tim Cunningham joins as Chief Financial Officer ADELAIDE, Australia and CAMBRIDGE, Mass., July 0...

July 3, 2023, 10:00 am

Vir biotechnology presents new data evaluating the potential for vir-2218 and vir-3434 as therapies for chronic hepatitis b and hepatitis d

– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomo...

June 24, 2023, 9:30 am

Gri bio (nasdaq: gri) to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest

– Live webcast fireside chat on Thursday, June 22nd at 12:00 PM ET LA JOLLA, CA, June 15, 2023 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“...

June 15, 2023, 12:45 pm

Bionomics announces upcoming poster presentation at the american society of clinical psychopharmacology (ascp) annual meeting

ADELAIDE, Australia and CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clin...

May 30, 2023, 10:00 am

Cohbar, inc. and morphogenesis, inc. enter into definitive merger agreement to advance an innovative late-stage clinical immuno-oncology pipeline of therapies to overcome resistance to cancer immunoth

Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer vaccine platform and preclinical tumor m...

May 23, 2023, 11:30 am

The taste modulators market is estimated to reach us$ 3.0 billion by 2033, with a cagr of 6.3% from 2023 to 2033, report by future market insights, inc.

The use of sweet taste modulators in huge amounts in the beverage sector around the world promotes mark...

February 2, 2023, 1:30 am

Quarterly activities and cashflow report

ADELAIDE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO,), (Bionomics or the Company) a clinical-stage biop...

January 30, 2023, 11:23 pm

Bionomics announces accepted abstract and upcoming poster presentations at the american college of neuropsychopharmacology (acnp) 2022 annual meeting

ADELAIDE, Australia, Dec. 02, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharma...

December 2, 2022, 11:00 am

Vertex to present data demonstrating significant benefits of long-term and early treatment with cftr modulators at the european cystic fibrosis conference

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that five scientific abstracts on the company's portfolio ...

June 10, 2022, 11:00 am

Merck inks oncology, neurology drug discovery pact with british biotech, curve therapeutics

Privately-held Curve Therapeutics has inked a contract with Merck & Co Inc (NYSE: MRK) to discover and validate ...

February 16, 2022, 2:01 pm

Merck inks oncology, neurology drug discovery pact with british biotech, curve therapeutics

Privately-held Curve Therapeutics has inked a contract with Merck & Co Inc (NYSE: MRK) to discover and validate ...

February 16, 2022, 2:01 pm

Merck inks oncology, neurology drug discovery pact with british biotech, curve therapeutics

Privately-held Curve Therapeutics has inked a contract with Merck & Co Inc (NYSE: MRK) to discover and validate ...

February 16, 2022, 2:01 pm

Medicenna therapeutics: treating cancer with immunomodulators

Medicenna Therapeutics has engineered super-versions of interleukins, proteins that mediate communication between cells. Medicenna's candidate for tre...

November 12, 2021, 9:34 pm

Medicenna therapeutics: treating cancer with immunomodulators

Medicenna Therapeutics has engineered super-versions of interleukins, proteins that mediate communication between cells. Medicenna's candidate for tre...

November 12, 2021, 9:34 pm

Medicenna therapeutics: treating cancer with immunomodulators

Medicenna Therapeutics has engineered super-versions of interleukins, proteins that mediate communication between cells. Medicenna's candidate for tre...

November 12, 2021, 9:34 pm


Search within

Pages Search Results: